Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Oftalma AB
AB
Active
Org 5594259342
Orrholmsgatan 7 A, 652 15
Karlstad
Medical specialists activities
·
NACE 8622
Est. 2023 · 3 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
Oftalma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
4M
3M
2M
1M
0M
2023: 2M
2M
2023
2024: 3M (+50% vs 2023)
3M
+50%
2024
2025: 2M (-33% vs 2024)
2M
-33%
2025
EBITDA
SEK millions
2M
2M
1M
1M
0M
2023: 1M
1M
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
2025: 1M (-50% vs 2024)
1M
-50%
2025
Income statement
SEK thousands
Item
2025
2024
2023
Revenue
2 351
3 165
2 325
Staff expenses
−927
−974
−784
EBITDA
884
1 673
1 373
Depreciation & amort.
—
—
—
EBIT
884
1 673
1 373
Net financials
−5
−0
—
Profit before tax
650
1 252
1 033
Tax
−141
−262
−213
Net profit
509
990
821
Balance sheet
SEK thousands
Item
2025
2024
2023
Total assets
3 108
2 982
1 989
Equity
1 815
1 636
846
Long-term debt
—
—
—
Short-term debt
305
586
803
Total debt
305
586
803
Financial ratios
5-year trend
EBITDA margin
37,6 %
This company
15,8 %
Market median
This company
Market median
138% above market
2023
2025
Equity ratio
58,4 %
This company
38,2 %
Market median
This company
Market median
53% above market
2023
2025
Return on equity
28,0 %
This company
18,4 %
Market median
This company
Market median
52% above market
2023
2025
Net profit margin
21,6 %
This company
8,1 %
Market median
This company
Market median
167% above market
2023
2025
Asset turnover
0,76×
This company
1,12×
Market median
This company
Market median
32% below market
2023
2025
Debt / equity
0,71×
This company
0,62×
Market median
This company
Market median
15% above market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-03-13 – 2023-12-31
View
PDF
More on Oftalma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
